The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Sigmund Silber

Showing 1-18 of 18 articles
Identification of the type of stent with three-dimensional optical coherence tomography: the SPQR study
Cortes C, Chu M, Schincariol M, Martínez-Hervás Alonso M, Reisbeck B, Zhang R, Murasato Y, Chen S, Lavarra F, Tu S, Silber S, Gutiérrez-Chico J
June 11, 2021 | 10.4244/EIJ-D-20-00598
Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions
Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S
March 19, 2021 | 10.4244/EIJ-D-19-00866
Coronary interventions
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial
Fajadet J, Neumann F, Hildick-Smith D, Petronio A, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S
January 20, 2017 | 10.4244/EIJV12I13A262
Coronary interventions
Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program
Di Mario C, Serruys P, Silber S, Lu S, Wang W, Widimsky P, Xu B, Windecker S
November 20, 2016 | 10.4244/EIJV12I10A199
Coronary interventions
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program
Abdel-Wahab M, Neumann F, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimsky P, Meredith I, Saito S, Richardt G
July 20, 2016 | 10.4244/EIJY15M07_07
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions
Kelbæk H, Holmvang L, Richardt G, Eberli F, Stella P, Buszman P, Neumann F, Serruys P, Windecker S, Widimsky P, Belardi J, Silber S
October 20, 2015 | 10.4244/EIJY14M07_14
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial
Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P
September 22, 2015 | 10.4244/EIJY14M12_13
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention
Vranckx P, Kalesan B, Stefanini G, Farooq V, Onuma Y, Silber S, de Vries T, Jüni P, Serruys P, Windecker S
June 19, 2015 | 10.4244/EIJV11I2A31
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment
Stella P, Belkacemi A, Waksman R, Stahnke S, Torguson R, Von Strandmann R, Agostoni P, Sangiorgi G, Silber S
October 28, 2011 | 10.4244/EIJV7I6A113
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial
Silber S, Gutiérrez-Chico J-L, Behrens S, Witzenbichler B, Wiemer M, Hoffmann S, Slagboom T, Harald D, Suryapranata H, Nienaber C, Naber C, Chevalier B, Serruys P
May 17, 2011 | 10.4244/EIJV7I1A13
Clinical results after coronary stenting with the GenousTM Bio-engineered R stentTM: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry
Silber S, Damman P, Klomp M, Beijk M, Grisold M, Ribeiro E, Suryapranata H, Wójcik J, Sim K, Thijssen J, de Winter R
February 21, 2011
Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity
Vranckx P, Cutlip D, Mehran R, Kint P-P, Silber S, Windecker S, Serruys P
February 25, 2010
Transferability of data between different drug-eluting stents
Magro M, Onuma Y, Silber S, Serruys P
November 15, 2009 | 10.4244/EIJV5I5A85
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007
Daemen J, Simoons M, Wijns W, Bagust A, Bos G, Bowen J, Braunwald E, Camenzind E, Chevalier B, Di Mario C, Fajadet J, Gitt A, Guagliumi G, Hillege H, James S, Jüni P, Kastrati A, Kloth S, Kristensen S, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys P, Silber S, Steg P, Tariah I, Wallentin L, Windecker S
January 20, 2009
Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™
Duckers H, Soullié T, den Heijer P, Rensing B, de Winter R, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys P
November 20, 2007
'Fused-Gold' vs. 'Bare' stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP Study
Fort S, Kornowski R, Silber S, Lewis B, Bilodeau L, Almagor Y, van Remortel E, Morice M, Colombo A
August 20, 2007
Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent
Duckers H, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys P
May 22, 2007
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial
Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D
February 20, 2007

Latest news

NEW ISSUE
Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more
September 20, 2021
STATE OF THE ART
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Rafael Beyar et al.
September 20, 2021
AHEAD OF PRINT
ViV TAVI vs repeat SAVR
Monil Majmundar et al.
September 15, 2021
AHEAD OF PRINT
Thrombectomy for ischaemic stroke
Christopher A. Rajkumar et al.
September 10, 2021
EDITORIAL
Walking the tightrope between ischaemia and bleeding
Michelle L. O’Donoghue et al.
September 20, 2021
EDITORIAL
Microvascular dysfunction endotypes and outcomes
Christos V. Bourantas et al.
September 20, 2021
EDITORIAL
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?
Michael Foley et al.
September 20, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke